Literature DB >> 11457511

An introduction to neuronal cholecystokinin.

M C Beinfeld1.   

Abstract

This issue of Peptides was inspired by a gathering of CCK researchers at the first Neuronal Cholecsytokinin Gordon Conference. The papers in this issue reflect the diversity of CCK research and demonstrate how the field has matured. Reviews describe the regulation of CCK gene expression and CCK release, the nature of the hormone binding site of the CCK A receptor, interaction of CCK, dopamine and GABA, the role of CCK in thermoregulation, sexual behavior and satiety in rodents and humans. The research articles document features of cardiovascular regulation, reduced cocaine sensitization and decreased satiety in rats that lack the CCK A receptor. Pro CCK processing in neuroblastoma cells and the elevation of CCK levels in CSF in a model of chronic pain are detailed in other articles. Three articles using different behavioral paradigms in rat and sheep examine CCK in learning and memory. Two articles that examine CCK in different behaviors that have a dopaminergic component are included. Other articles describe the interaction between a 5HT(3) antagonist and CCK-induced satiety and c-fos activation and document secretion of oxytocin and vasopressin in female patients and controls in response to CCK 4 administration. There is good reason to believe that the future is bright for research on CCK. With the organization of national and international meetings, CCK researchers have a forum for communication. Opportunities for cooperation and collaboration have never been better. The easy integration of academic basic and clinical science with industrial science bodes very well for the advancement of our understanding of the multiple roles that CCK plays in the brain and for the future development of CCK-based therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457511     DOI: 10.1016/s0196-9781(01)00442-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

1.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

Review 2.  Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.

Authors:  Paige V Bauer; Sophie C Hamr; Frank A Duca
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

3.  Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.

Authors:  Shouping Wang; An-Ping Zhang; Lalitha Kurada; Toshimitsu Matsui; Saobo Lei
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

4.  Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice.

Authors:  C Del Boca; P E Lutz; J Le Merrer; P Koebel; B L Kieffer
Journal:  Neuroscience       Date:  2012-05-18       Impact factor: 3.590

Review 5.  Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications.

Authors:  Yvonne M Ulrich-Lai; Karen K Ryan
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

6.  Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.

Authors:  Mitsuko Hamamura; Hidetoshi Ozawa; Miwako Ozaki; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2010-08-03       Impact factor: 3.575

Review 7.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

8.  Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.

Authors:  Pan-Yue Deng; Zhaoyang Xiao; Archana Jha; David Ramonet; Toshimitsu Matsui; Michael Leitges; Hee-Sup Shin; James E Porter; Jonathan D Geiger; Saobo Lei
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

Review 9.  Cholecystokinin-induced gastroprotection: a review of current protective mechanisms.

Authors:  Sonlee D West; David W Mercer
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

10.  Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Authors:  Dongjun Dai; Yunliang Wang; Jiaojiao Yuan; Xingyu Zhou; Danjie Jiang; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.